Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HAL vs MRNA✓SelectedUSD · MRNAHAL vs MRNA performance historyLatest closeAs of+3.11%11/13
Stock and ETF performance explorer

HAL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+57.7%
MRNA return
-4.5%
Excess return
+62.3%
Maximum drawdown
-54.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+3.1%-3.4%+6.6%+3.2%
7D+6.1%-12.1%+18.2%+6.4%
30D+2.9%-1.3%+4.2%+2.8%
3M+3.3%+250.9%-247.6%-2.1%
6M-16.9%+343.0%-359.9%-22.9%
YTD+21.2%+657.4%-636.3%+7.4%
1Y+27.5%+794.9%-767.4%+11.5%
3Y-6.4%+218.1%-224.6%-15.2%
All+57.7%-4.5%+62.3%+41.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling